Author

Nuha Ahmad

Institution: Hamad Medical Corporation

Observed institution: Hamad Medical Corporation

OpenAlex ID: A5111257045

H2AX: A key player in DNA damage response and a promising target for cancer therapy

2024 · Kirti S. Prabhu, Shilpa Kuttikrishnan, et al. · Biomedicine & Pharmacotherapy · 189

Anticancer Potential and Molecular Targets of Pristimerin in Human Malignancies

2024 · Kirti Prabhu, Serah Jessy, et al. · Pharmaceuticals · 10

Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target

2024 · Nuha Ahmad, Safwan Moton, et al. · Pathology - Research and Practice · 5

Works count: 3

Citation count: 204

H-index: 3

I10-index: 2